FACTORS AFFECTING ADHERENCE TO RECOMMENDED MEDICATIONS AMONG PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN A SELECTED TEACHING HOSPITAL, SRI LANKA
DOI:
https://doi.org/10.29121/granthaalayah.v7.i9.2019.553Keywords:
COPD, Adherence, COPD Medications, Sri LankaAbstract [English]
Background: This study was conducted to determine the prevalence of adherence and factors affecting adherence to recommended medications among patients with COPD in a selected teaching hospital, Sri Lanka.
Method: A descriptive cross-sectional design was used among conveniently selected (n=184) participants who attended to the Colombo South Teaching Hospital, Sri Lanka. Data were collected using a pre-tested (n=10) interviewer-administered questionnaire and Morisky Green Levine Scale from January to March 2019.
Results: Most of the participants were male (108, 58.7%) and above 65 years old (108, 58.7%). Among all participants, 121 (65.8%) adhered to the recommended medications for COPD, and 63 participants (34.2%) were non-adhered. Demographic factors were not associated with adherence. Number of prescribed respiratory drug classes, number of respiratory medication on the last prescription, number of doses per day, vaccination (pneumococcal, influenza), using an electronic device to remember the time of administering medicine, (p<0.05) were significantly associated with adherence. According to the binary logistic regression analysis, clear and understandable written instructions in dispensing label (p<0.05) were significantly associated with adherence.
Conclusions: Most of the participants adhered to the recommended medications for COPD. Health education interventions might enhance the sustainability of adherence to recommended medication among patients with COPD.
Downloads
References
Global Initiative for Chronic Obstructive Lung Disease (2017) Journal of Cardiopulmonary Rehabilitation. doi: 10.1097/00008483-200207000-00004. DOI: https://doi.org/10.1097/00008483-200207000-00004
Global Initiative for Chronic Obstructive Lung Disease (2018) Global Initiative for Chronic Obstructive Lung Disease, Inc. doi: http://dx.doi.org/10.1164/rccm.201701-0218PP. DOI: https://doi.org/10.1164/rccm.201701-0218PP
Xu, F. et al. (2005) ‘Prevalence of physician-diagnosed COPD and its association with smoking among urban and rural residents in regional mainland China’, Chest. doi: 10.1378/chest.128.4.2818. DOI: https://doi.org/10.1378/chest.128.4.2818
Global surveillance, prevention and control of chronic respiratory diseases (2007). doi: ISBN 978 92 4 156346 8.
Amarasiri, L. et al. (2017) ‘The prevalence of Chronic Obstructive Pulmonary Disease (COPD) in Sri Lanka: outcome of the BOLD study’. Available at: http://erj.ersjournals.com/content/50/suppl_61/PA1212.
World Health Organization (2003) ‘Adherence to long-term therapies: Evidence for action’, European Journal of Cardiovascular Nursing, 2(4), p. 323. doi: 10.1016/S1474-5151(03)00091-4. DOI: https://doi.org/10.1016/S1474-5151(03)00091-4
Tabor, P. A. and Lopez, D. A. (2004) ‘Comply with Us: Improving Medication Adherence’, Journal of Pharmacy Practice, 17(3), pp. 167–181. doi: 10.1177/0897190004264816. DOI: https://doi.org/10.1177/0897190004264816
David, J. G., Kong, C. M. and Stewart, K. (2007) Adherence to disease management programs in patients with COPD, International Journal of COPD.
Khdour, M. R. et al. (2012) ‘Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD)’, European Journal of Clinical Pharmacology. doi: 10.1007/s00228-012-1279-5. DOI: https://doi.org/10.1007/s00228-012-1279-5
Agh, T., Inotai, A. and Meszaros, A. (2011) ‘Factors associated with medication adherence in patients with chronic obstructive pulmonary disease’, Respiration. doi: 10.1159/000324453. DOI: https://doi.org/10.1159/000324453
Oca, M. M. de et al. (2016) ‘Adherence to inhaled therapies of COPD patients from seven Latin American countries: The LASSYC study’, PLoS ONE. doi: 10.1371/journal.
Dhamane, A. D. et al. (2016) ‘Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients’, International Journal of COPD. doi: 10.2147/COPD.S114802. DOI: https://doi.org/10.2147/COPD.S114802
Perez, X., Wisnivesky, J.P., Lurslurchachai, L., Kleinman, L.C. and Kronish, I.M., 2012. ‘Barriers to adherence to COPD guidelines among primary care providers’. Respiratory medicine, 106(3), pp.374-381. DOI: https://doi.org/10.1016/j.rmed.2011.09.010
Vervloet, M., Linn, A. J., van Weert, J. C., de Bakker, D. H., Bouvy, M. L., & van Dijk, L. (2012). ‘The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature’. Journal of the American Medical Informatics Association: JAMIA, 19(5), 696–704. doi:10.1136/amiajnl-2011-000748 DOI: https://doi.org/10.1136/amiajnl-2011-000748
Thakkar, J., Kurup, R., Laba, T.L., Santo, K., Thiagalingam, A., Rodgers, A., Woodward, M., Redfern, J. and Chow, C.K., 2016. Mobile telephone text messaging for medication adherence in chronic disease: a meta-analysis. JAMA internal medicine, 176(3), pp.340-349. DOI: https://doi.org/10.1001/jamainternmed.2015.7667
Jimmy, B. and Jose, J., 2011. Patient medication adherence: measures in daily practice: Oman medical journal, 26(3), p.155. DOI: https://doi.org/10.5001/omj.2011.38
Wiśniewski, D. et al. (2014) ‘Factors influencing adherence to treatment in COPD patients and its relationship with disease exacerbations’, Pneumonologia i Alergologia Polska, 82(2), pp. 96–104. doi: 10.5603/PiAP.2014.0015. DOI: https://doi.org/10.5603/PiAP.2014.0015
Miravitlles, M. et al. (2018) ‘Factors affecting the selection of an inhaler device for COPD and the ideal device for different patient profiles. Results of EPOCA Delphi consensus’, Pulmonary Pharmacology and Therapeutics. Elsevier Ltd, 48, pp. 97–103. doi: 10.1016/j.pupt.2017.10.006. DOI: https://doi.org/10.1016/j.pupt.2017.10.006
Samankantha, S. et al. (2017) ‘Descriptive analysis of risk factors in a COPD cohort in central Sri Lanka’, Respirology. doi: 10.1111/resp.13207_421. DOI: https://doi.org/10.1111/resp.13207_421
Downloads
Published
How to Cite
Issue
Section
License
With the licence CC-BY, authors retain the copyright, allowing anyone to download, reuse, re-print, modify, distribute, and/or copy their contribution. The work must be properly attributed to its author.
It is not necessary to ask for further permission from the author or journal board.
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
